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Abstract
Purpose A study was conducted to compare minimum 15-
year survivorship and outcome of the Genesis I and II im-
plants for total knee arthroplasty (TKA).
Methods We retrospectively reviewed 245 consecutive TKA
implanted between January 1995 and October 1997. Genesis I
was implanted in 156 knees and Genesis II in 89 knees.
Results At 15–17 years, 75 patients (31 %) had died, 28
patients (11 %) were lost to follow-up and 11 TKA were
revised (4.6 %), including ten Genesis I (6.4 %) and one
Genesis II (1.1 %); 131 TKA (53 %) were available for
follow-up. Cumulative survivorship was 92.4 % at 15.7 years.
Survival in patients <69 years at surgery was lower (88.0 %)
compared with patients ≥69 years (98.5 %; p =0.023). In
patients <69 years, Genesis I survival (84.3 %) was worse
compared with Genesis II (97.1 %) (p =0.018). Polyethylene
(PE) Insert thickness ≤11 mm had significantly better survi-
vorship (97.1 %) compared with PE >11 mm (56.7 %)
(p <0.0001)
Conclusions At a minimum of 15 years, the overall (92.4 %)
survivorship of Genesis TKA was good, with excellent
(98.1 %) survivorship of the Genesis II design. Revision rates
were higher with Genesis I in the younger age group and with
insert thickness >11 mm, possibly due to longer shelf life of
less frequently used sizes.
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Introduction
Total knee arthroplasty (TKA) is a common orthopaedic pro-
cedure performed with increasing frequency [1]. Outcome is
described as the function of several variables, including sur-
vival [2], kinematics [3], function [4] and patient satisfaction
[5]. None of these approaches covers the full spectrum of
reality. Historic papers reporting long-term results are still
used as benchmarks in the orthopaedic literature [6, 7] but
often deal with obsolete implants and outdated patient selec-
tion criteria, large dropout numbers and changes in patient
function and activity over 15–20 years. The current patient
profile for TKA in terms of age and disease progression is
quite different from historic publications [8]. In the United
States, the demand for primary TKA among patients <65 years
is predicted to exceed 50 % of TKA patients by 2016 [8]. For
arthritic patients with 20–40 years remaining life expectancy,
reliable long-term follow-up data on TKA are a sound basis
for decision making. Therefore, studies on longer-term
follow-up after TKA performed in the past decade [7, 9–18]
deserve further attention, despite the logistic problems and
limitations. Besides, reliable long-term data on implants still
in use can serve to evaluate quality and performance of new
devices.
In this study, we analysed two different TKA designs:
Genesis I and Genesis II (Smith & Nephew, Memphis, TN,
USA) at 15–17 years follow-up. Genesis I is no longer com-
monly implanted, whereas Genesis II is still widely used.
Despite the similarity in name, the two implants have different
geometry. Genesis I was one of the first modular implants with
a built-up module to convert the device from a cruciate-
retaining (CR) to a posterior stabilised (PS) design by
resecting an additional extra 4 mm from the distal femur on
top of the regular 9-mm resection. The polyethylene (PE) post
was tall, and accommodation of the femoral box required
significant bone removal. In comparison, the Genesis II
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implant has a nonmodular, distinct CR and PS component,
with a more rounded and less prominent post. Also, tibial
coverage and the trochlear groove on the femoral component
are more anatomic. Hence our research questions were: (1)
What is the survivorship and clinical outcome of a consecutive
series of TKA at 15–17 years of follow-up? (2) Is there a
difference in outcome between the two TKA designs? (3) Can
determinant implant and patient factors be established?
Patients and methods
Between January 1995 and October 1997, 245 consecutive
primary TKA were performed on 220 patients by a single
surgeon (JV). Cohort 1 consisted of 156 Genesis I knees and
cohort 2 of 89 Genesis II knees. Patients were operated
through a standard anteromedial approach. The patella was
everted and resurfaced in all cases. Femoral alignment was
guided by an intramedullary rod and tibial alignment by an
extramedullary rod. Knees were implanted with a measured
resection technique and standard instrumentation. The choice
for a CR or PS implant was made after assessment of defor-
mity and ligament status. All tibial and patellar components
were cemented. Femoral fixation included both uncemented
and cemented cases.
Clinical and radiographic data were documented in a pro-
spective database. Pre-operative and six week postoperative
imaging included full-leg, standing X-rays and standing
anteroposterior (AP), lateral and skyline views.At 15–17years
of follow-up, patients were examined by an independent study
nurse. Range of motion (ROM), stability and swelling were
noted. Knee Society Score (KSS) [19] and Knee Injury and
Osteoarthritis Outcome Score (KOOS) [20] were computed.
Radiolucent lines were documented on AP and lateral views,
according to the Knee Society scoring system [21]. Alignment
was measured on full-leg views, represented as the hip-knee-
ankle (HKA) angle (angle formed between the tibial and
femoral mechanical axes in the coronal plane). PE thickness
was measured on AP views of the medial and lateral compart-
ment (Fig. 1). The estimated amount of linear wear was
calculated by deducting the measured thickness, corrected
for magnification, from the initial PE thickness, as disclosed
by the manufacturer.
Statistical analysis
Data analysis was performed using IBM-SPSS Statistics 21
(SPSS, an IBM Company, Chicago, IL, USA). Level of sta-
tistical significance was 0.05. Research questions were exam-
ined as follows: (1) Kaplan-Meier survivorship analysis was
performed for the total cohort; clinical and radiographic out-
come were analysed for the nonrevised knees available at the
15- to 17-year follow-up. (2) Comparison of survival of the
two TKA designs was performed using the log rank (Mantel-
Cox) test. (3) In order to establish determinant patient and
implant factors, subanalysis was performed by gender, age at
surgery, body mass index (BMI), femoral fixation mode and
PE insert thickness using parametric or nonparametric tests, as
appropriate. Log-rank test was used to establish the difference
in implant survivorship between subgroups.
Results
Pre-operative demographic distribution of the two cohorts was
comparable in terms of gender, BMI, clinical scores, varus/
valgus distribution and amount of pre-operative coronal de-
formity (p >0.1) (Table 1). Mean age at surgery was signifi-
cantly lower in the Genesis II cohort (p =0.016). Distribution
of femoral component fixation mode and PE insert thickness
was similar.
At 15–17 years, 69 patients with 75 TKA (30.6 %) had
died, and 25 patients with 28 TKA (11.4 %) were lost to
follow-up (Fig. 2). Overall, mean follow-up was 11.0 (0.5–
16) years. In all but two lost patients, files indicated an
uneventful course at last follow-up. One patient (Genesis I,
PS), lost at 11 years, complained of mild pain. He had under-
gone TKA after a complex tibial fracture. The tibial compo-
nent displayed 4° varus without radiolucent lines. The other
symptomatic patient (Genesis II, PS) was lost after three years,
with mild complaints related to the extensor mechanism.
Fig. 1 Polyethylene (PE) thickness of medial and lateral compartments
measured on anteroposterior radiographs. The estimated amount of linear
wear was calculated by deducting the measured thickness, corrected for
magnification, from the initial PE thickness, as disclosed by the
manufacturer
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Patellar tracking and fixation was fine. All patients in the lost
cohort would presently be at least 80 years old (mean age 87,
range 80–105), hence, most are probably deceased. Eleven
TKA (in ten patients) were revised, including ten Genesis I for
infection (1), recurrent dislocation (1), femoral component
loosening (1), patella loosening (2) or PE wear (5), and one
Genesis II for PE wear (Table 2).
The remaining 116 patients with 131 TKA (53.4 %) could
be contacted for the 15- to 17-year follow-up. In 64 patients
who were unfit to come to the clinic because of advanced age
(mean 83 years) or disease, data were gathered via a telephone
interview (71 TKA). Clinical and radiological examination
was obtained in 52 patients (60 TKA) (Fig. 2).
Outcome at 15–17 years
KSS improved from 39 [standard deviation (SD 16.5)] to 81
(SD 9.2) in Genesis I and from 41 (SD 14.1) to 83 (SD 10.3) in
Genesis II. Postoperative KOOS scores for symptoms, pain,
daily activity and quality of life were similar in both groups
(mean total KOOS Genesis I, 86 (SD 33), Genesis II 89 (SD
40); p >0.1). Radiographs six weeks postoperatively revealed
varus deformity (HKA > 3°) in 26 knees (range 4–5.5°) and
valgus deformity (HKA < −3°) in 13 knees (range −3.5° to
−5°). At 15–17 years postoperatively, 60 TKA (30 in each
cohort) were analysed. Radiolucencies of 1 mm were noted in
two cases on the tibial side and one case on the femoral side.
No patellar radiolucencies were observed. In Genesis I, wear
on the medial side averaged 0.76 mm (SD 0.53) versus 0.89
(SD 0.52) on the lateral side; in Genesis II, these values were
0.82 (SD 0.52) and 0.79 (SD 0.50), respectively. There was no
difference between groups (p >0.1) .
Survivorship
Overall Kaplan-Meier cumulative survivorship was 92.4 % at
15.7 years [95 % confidence interval (CI) 91.0–93.7]. Survi-
vorship in the Genesis I group was 90.1 % at 15.5 years (95 %
Table 1 Demographics of the
study cohort and group
comparison
BMI body mass index, SD stan-
dard deviation
Genesis I Genesis II P value
Number 156 89
Gender M 26.9 %, F 73.1 % M 25 %, F 75 % 0.417
Age at surgery Mean 69.3 years (SD 9.45)
Median 69.4 years (27–89)
Mean 66.0 years (SD 9.61)
Median 67.9 years (27–84)
0.016
BMI Mean 28.5 (SD 4.77)
Median 27.5 (18.7–42.3)
Mean 28.4 (SD 5.03)
Median 28.7 (17.5–42.5)
0.811
Femoral component Cemented 75 (48 %)
Uncemented 81 (52 %)
Cemented 42 (47 %)
Uncemented 47 (53 %)
0.894
Insert size Median 10 mm
10 (83 %); 12 (15 %); 15 (2 %)
Median 11 mm
9 (41 %); 11 (51 %); 13 (7 %); 15 (1 %)
0.956
Varus/valgus 98/48 62/25 0.172
Fig. 2 All patients: dead, lost,
revised and available for 15–
17 years’ follow-up in the global
population and in the Genesis I
(Gen I) and Genesis II (Gen II)
cohorts
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CI 88.0–92.2) and in Genesis II 98.1 % at 15.0 years (95 % CI
97.8–98.3) (Fig. 3). The difference was not statistically sig-
nificant (Log rank 3.136; p =0.077).
There was no difference in survivorship between genders
(Log rank 0.184; p =0.668) or femoral component fixation
(Log rank 1.315; p =0.251). No difference in postoperative
coronal alignment between revised and nonrevised patients
was observed ( p <0.1); although revised patients had a mean
BMI of 31.5 (25–41), there was no difference in survivorship
between BMI <30 and ≥30 (Log rank 1.403; p =0.236). TKA
survival in patients <69 years (overall median age) at surgery
was significantly worse (88.0 % at 15.4 years; 95 % CI 85.8–
90.4) compared with patients of ≥69 years at surgery (98.5 %
at 15.9 years; 95 % CI 97.4–99.6; Log rank 5.135; p =0.023)
(Fig. 4). In patients <69 years, survivorship of Genesis II was
significantly better (97.1 %; 95 % CI 96.7–97.5) compared
with 84.3 % (95 %; CI 80.5–88.1) for Genesis I (Log rank
5.598; p =0.018). The odds ratio (OR) for revision of a
Genesis I implant was 12.2 compared with a Genesis II.
Analysis of different insert size groups revealed significant-
ly worse implant survival with PE thickness >11 mm (56.7 %
at 14.0 years; 95 % CI 49.5–62.9), which were less frequently
used (13.9 % of inserts) compared with PE thickness ≤11 mm
(97.1 % at 15.9 years; 95 % CI 96.5–97.7) (Log rank 45.657;
p <0.0001) (Fig. 5). The OR for revision of a PE insert
>11 mm was 35.3.
Table 2 Details of revised cases of Generation (Gen) I and II total knee arthroplasty (TKA)
Patient Age at surgery BMI TKA type Constraint/ fixation Insert size PE sterilisation Revised at Failure mode
1 F 66 25 Gen I PS/C 12 Gamma 1 year Infection
2 F 67 36 Gen I PS/C 12 Gamma 1 year Dislocation
3 F 64 35 Gen I CR/UC 10 EtO 9 years Patella loosening
4 M 63 27 Gen I PS/C 15 Gamma 10 years Patella loosening
5 F 68 25 Gen I CR/UC 12 Gamma 12 years PE wear /instability
6 M 64 27 Gen I PS/C 15 Gamma 13 years PE wear /infection
7 F 71 41 Gen I CR/UC 12 EtO 11 years Femoral loosening
8 F 60 32 Gen I PS/C 10 EtO 15 years PE wear
9 F 62 37 Gen I PS/C 12 Gamma 13 years PE wear/loosening
61 Gen I CR/UC 12 Gamma 15 years PE wear
10 F 27 30 Gen II PS/C 11 EtO 15 years PE wear/Instability
BMI body mass index, PS posterior stabilized, CR cruciate retaining, C cemented, UC uncemented, PE polyethylene, EtO ethylene oxide
Fig. 3 Survivorship in the
Genesis I group was 90.1 % at
15.5 years [95 % confidence
interval (CI) 88.0 – 92.2) and in
the Genesis II group 98.1 % at
15.0 years (95 % CI 97.8 – 98.3).
The difference was not
statistically significant (Log rank
3.136; p =0.077)
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Discussion
This study describes the long-term outcome of a consecutive
series of 245 TKA in 220 patients consisting of two cohorts of
different Genesis implants. Overall, the 92.4% survivorship at
15.7 years is good, with excellent 98.1 % survivorship of the
Genesis II design. The main weakness of the study is the
number of dropouts. At 15–17 years, 69 patients had died
and 25 were lost to follow-up. Lost patients were >80 years at
the time of evaluation; hence, it is logical to assume that many
of them had died. In addition, only two of these patients were
symptomatic at last follow-up. Advanced age in the majority
Fig. 4 Total knee arthroplasty
(TKA) survival in patients
<69 years (overall median age) at
surgery was significantly worse
[88.0 % at 15.4 years; 95 %
confidence interval (CI) 85.8 –
90.4] compared with patients
≥69 years at surgery (98.5 % at
15.9 years; 95 % CI 97.4 – 99.6);
p =0.023
Fig. 5 Survival with
polyethylene (PE) thickness
>11 mm [56.7 % at 14.0 years;
95 % confidence interval (CI)
49.5–62.9] was significantly
worse compared with PE
thickness ≤11 mm (97.1 % at
15.9 yearsl; 95 % CI 96.5 –97.7);
p <0.0001
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of patients is a typical phenomenon of long-term joint replace-
ment studies, reducing function scores as a discriminative
parameter [17]. Callaghan et al. reported on 26 living patients
remaining from an initial cohort of 86 patients. Despite the
excellent KSS of 89, the function score dropped to 67. [17]
Minimum 15-year follow-up reports after TKA are not
abundant, and several publications deal with implants no
longer commonly used. Van Loon et al. followed 102
cemented Kinematic TKA (Howmedica, Rutherford, NJ,
USA) at ten to 15 years after surgery and reported 62 %
survival at 14 years, with deep infection and wear being the
main reasons for revision [10]. Buechel reported 83 % surviv-
al of the meniscal-bearing PC-retaining LCS prosthesis
(DePuyWarsaw, IN, USA) at 16 years [11]. Ito et al. examined
a cohort of 36 Kinematic knees in 25 patients with rheumatoid
arthritis and reported 93.7 % survival at 15 years [12]. Dixon
et al. found 95.6 % survival at 15 years in 139 PC-retaining
press-fit condylar (PFC) prostheses (DePuy), with PE wear as
the leading cause for reoperation [13]. Less-favourable results
of this implant (85 % survivorship at 15 years) were reported
by Duffy et al. due to PE wear and osteolysis from ten years
onwards [14]. Baker et al. confirmed these relatively high
failure rates at 15-years’ follow-up in 501 primary PFC
TKA. Survivorship for cemented implants was 80.7 % and
for cementless implants 75.3 % [15]. Paratte et al. studied a
cohort of different implants and assessed coronal alignment as
a predictive parameter for implant survival. They reported
overall survival of 86 % at 15 years [16].
In contrast to the latter findings, we were unable to detect a
correlation between postoperative alignment or femoral com-
ponent fixation and odds for failure. On the other hand, we
found a significant difference in survivorship between thinner
and thicker PE inserts. Insert sizes >11 mm had a low survival
of 56.7 % at 14 years. As these sizes were used less frequently
(13.9 % of total), their shelf life may have been longer.
Especially in the Genesis I cohort, where gamma radiation
in air was still in use as a sterilisation method, this may have
caused PE degradation and increased wear, leading to implant
failure [22].
Long-term comparative studies of different TKA implant
designs are scarce. Kim et al. compared long-term follow-up
between two different implants in 108 patients who <51 years
at the time of surgery. The patients received an AMK fixed-
bearing knee on one side and an LCS mobile-bearing TKA
(both DePuy) on the other side. Survivorship at 16.8 year was
95 % for the fixed-bearing knees and 97 % for the mobile-
bearing implants [18]. In our comparative study, the Genesis I
is no longer commonly in use, but the implant in Genesis II is
still widely used. Genesis II TKA with the more anatomic
tibial coverage and trochlear design demonstrated superior
survival rates compared with Genesis I, but the difference
was only statistically significant in the younger age group
(<69 at surgery). In the surviving TKA, there was no
difference in clinical (KOOS) or radiographic outcome be-
tween cohorts. Several reports on the Genesis II implant are
available but none with a 15-year follow-up [23–25]. Two
prospective, randomized studies compared cruciate-retaining
and substituting TKA with this implant and detected no sig-
nificant difference in function between groups [23, 24].
Bourne et al. [25] reported 98% survival at a mean of 9.5 (five
to 11) years’ follow-up , supporting data obtained in our study.
With regard to patient-related factors, in our study, implant
survival was worse in women (91.6 % versus 94.8 % in men)
and individuals with BMI ≥30 (83.5 % versus 93.5 % with
BMI <30); those differences were not statistically significant.
Only younger age (<69 years) at surgery significantly in-
creased the revision risk. A recent report from the Finnish
Arthroplasty Registry on 32019 TKA confirms the higher
revision risk in patients <65 at surgery [26].
In conclusion, we reported good (92.4 %) survivorship in a
group of 245 Genesis TKA at 15–17 years’ follow-up and
superior (98.3 %) survival of the Genesis II design. Revision
risk was significantly increased with younger age (<69 years)
at surgery and with PE thickness >11 mm, possibly related to
longer shelf life in less frequently used insert sizes.
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